日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in a rural population of Salem, Tamil Nadu

泰米尔纳德邦塞勒姆农村地区高血压患者血压控制不佳的患病率及相关因素

Radhakrishnan, Shankar; Arunthathi, B Sanjana; Arulprakash, S; Sangeetha, S

Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer

在胰腺癌患者来源的异种移植模型中,脂质体伊立替康的治疗指数高于非脂质体伊立替康。

Barbier, Sandrine; Beaufils, Benjamin; de Miguel, Ricardo; Reyre, Melissa; Le Meitour, Yannick; Lortie, Andreanne; de Boisferon, Marc Hillairet; Chaumeron, Sophie; Espirito, Anne; Fossati, Lina; Lagarde, Pauline; Klinz, Stephan; Thiagalingam, Arunthathi; Lezmi, Stéphane; Meyer-Losic, Florence

Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy

通过脂质体制剂和抗血管生成联合疗法增强伊立替康的实验性胃癌活性

Niranjan Awasthi, Margaret A Schwarz, Changhua Zhang, Stephan G Klinz, Florence Meyer-Losic, Benjamin Beaufils, Arunthathi Thiagalingam, Roderich E Schwarz

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

脂质体伊立替康治疗转移性乳腺癌患者的 I 期研究:扩展阶段的研究结果

Sachdev, Jasgit C; Munster, Pamela; Northfelt, Donald W; Han, Hyo Sook; Ma, Cynthia; Maxwell, Fiona; Wang, Tiffany; Belanger, Bruce; Zhang, Bin; Moore, Yan; Thiagalingam, Arunthathi; Anders, Carey

MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer

MicroRNA-4417 是一种肿瘤抑制因子,也是三阴性乳腺癌的预后生物标志物。

Wong, Chen Khuan; Gromisch, Christopher; Ozturk, Sait; Papageorgis, Panagiotis; Abdolmaleky, Hamid Mostafavi; Reinhard, Björn M; Thiagalingam, Arunthathi; Thiagalingam, Sam

Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder

异常转录组和 DNA 甲基化组定义了导致精神分裂症和躁郁症发病机制和大脑侧化/不对称性丧失的途径

Hamid M Abdolmaleky, Adam C Gower, Chen-Khuan Wong, Jiayi W Cox, Xiaoling Zhang, Arunthathi Thiagalingam, Rahim Shafa, Vadivelu Sivaraman, Jin-Rong Zhou, Sam Thiagalingam

Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors

生长抑素受体表达与神经内分泌肿瘤临床结果的关系

Zhi Rong Qian, Tingting Li, Monica Ter-Minassian, Juhong Yang, Jennifer A Chan, Lauren K Brais, Yohei Masugi, Arunthathi Thiaglingam, Nichole Brooks, Reiko Nishihara, Mireille Bonnemarie, Atsuhiro Masuda, Kentaro Inamura, Sun A Kim, Kosuke Mima, Yasutaka Sukawa, Ruoxu Dou, Xihong Lin, David C Christ

Smad signaling is required to maintain epigenetic silencing during breast cancer progression

Smad 信号是乳腺癌进展过程中维持表观遗传沉默的必要条件

Panagiotis Papageorgis, Arthur W Lambert, Sait Ozturk, Fangming Gao, Hongjie Pan, Upender Manne, Yuriy O Alekseyev, Arunthathi Thiagalingam, Hamid M Abdolmaleky, Marc Lenburg, Sam Thiagalingam